Plasma levels of antimicrobial peptide LL-37 as a biomarker of sleep quality in patients with obstructive sleep apnea: A clinical observational study
Takayuki Yamaguchi, Keisuke Hosokawa, Takenori Mineta, Rie Hosokawa, Shiho Odawara, Rie Chiba, Kazue Asanuma, Setsuko Toyomaki · 2026
Read Plasma levels of antimicrobial peptide LL-37 as a biomarker of sleep quality in patients with obstructive sleep apnea: A clinical observational study by Takayuki Yamaguchi, Keisuke Hosokawa, Takenori Mineta, Rie Hosokawa, Shiho Odawara, Rie Chiba, Kazue Asanuma, Setsuko Toyomaki (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0355855.txt.
Description
Takayuki Yamaguchi and colleagues measure a natural germ-fighting peptide in the blood of people with sleep apnea, the disorder where breathing repeatedly stalls at night. Apnea stirs body-wide inflammation and may weaken defenses against viruses. The team compared peptide levels in several dozen patients and healthy controls against detailed sleep study records, including how often breathing dipped and how much deep sleep each person got.
Peptide levels ran lower in patients with more severe apnea and tracked sleep quality closely: lower with more light, broken sleep and more breathing dips, higher with more deep and dreaming sleep. Light sleep share stood out as the independent link. Yamaguchi and colleagues propose the peptide as a blood marker worth testing for apnea's immune toll.
Catalog record
| CREATOR | Takayuki Yamaguchi, Keisuke Hosokawa, Takenori Mineta, Rie Hosokawa, Shiho Odawara, Rie Chiba, Kazue Asanuma, Setsuko Toyomaki |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32041 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |